BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Atique-ur-rehman H, Neill JC. Cognitive dysfunction in major depression: From assessment to novel therapies. Pharmacology & Therapeutics 2019;202:53-71. [DOI: 10.1016/j.pharmthera.2019.05.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Poletti S, Palladini M, Mazza MG, De Lorenzo R, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F; COVID-19 BioB Outpatient Clinic Study group. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci 2021. [PMID: 34698871 DOI: 10.1007/s00406-021-01346-9] [Reference Citation Analysis]
2 Xia CY, He J, Du LD, Yan Y, Lian WW, Xu JK, Zhang WK. Targeting the dysfunction of glutamate receptors for the development of novel antidepressants. Pharmacol Ther 2021;226:107875. [PMID: 33901503 DOI: 10.1016/j.pharmthera.2021.107875] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Zhang W, Zhu N, Lai J, Liu J, Ng CH, Chen J, Qian C, Du Y, Hu C, Chen J, Hu J, Wang Z, Zhou H, Xu Y, Fang Y, Shi C, Hu S. Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression. Neuropsychiatr Dis Treat 2020;16:2419-28. [PMID: 33116541 DOI: 10.2147/NDT.S266642] [Reference Citation Analysis]
4 Cordaro M, Cuzzocrea S, Crupi R. An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events. Antioxidants (Basel) 2020;9:E216. [PMID: 32150935 DOI: 10.3390/antiox9030216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
5 Wen D, Lang X, Zhang H, Li Q, Yin Q, Chen Y, Xu Y. Task and Non-task Brain Activation Differences for Assessment of Depression and Anxiety by fNIRS. Front Psychiatry 2021;12:758092. [PMID: 34803768 DOI: 10.3389/fpsyt.2021.758092] [Reference Citation Analysis]
6 Han YL, Dai ZP, Ridwan MC, Lin PH, Zhou HL, Wang HF, Yao ZJ, Lu Q. Connectivity of the Frontal Cortical Oscillatory Dynamics Underlying Inhibitory Control During a Go/No-Go Task as a Predictive Biomarker in Major Depression. Front Psychiatry 2020;11:707. [PMID: 32848905 DOI: 10.3389/fpsyt.2020.00707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Xie J, Bi B, Qin Y, Dong W, Zhong J, Li M, Cheng Y, Xu J, Wang H. Inhibition of phosphodiesterase-4 suppresses HMGB1/RAGE signaling pathway and NLRP3 inflammasome activation in mice exposed to chronic unpredictable mild stress. Brain Behav Immun 2021;92:67-77. [PMID: 33221489 DOI: 10.1016/j.bbi.2020.11.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhu Y, Wang R, Fan Z, Luo D, Cai G, Li X, Han J, Zhuo L, Zhang L, Zhang H, Li Y, Wu S. Taurine Alleviates Chronic Social Defeat Stress-Induced Depression by Protecting Cortical Neurons from Dendritic Spine Loss. Cell Mol Neurobiol 2022. [PMID: 35435537 DOI: 10.1007/s10571-022-01218-3] [Reference Citation Analysis]
9 Lang X, Wen D, Li Q, Yin Q, Wang M, Xu Y. fNIRS Evaluation of Frontal and Temporal Cortex Activation by Verbal Fluency Task and High-Level Cognition Task for Detecting Anxiety and Depression. Front Psychiatry 2021;12:690121. [PMID: 34267690 DOI: 10.3389/fpsyt.2021.690121] [Reference Citation Analysis]
10 Ngoupaye GT, Yassi FB, Bahane DAN, Pahaye DB, Ngo Bum E. Antidepressant and anti-amnesic effects of the aqueous lyophilisate of the leaves of Leptadenia arborea on an animal model of cognitive deficit associated depression. Biomed Pharmacother 2020;130:110603. [PMID: 34321164 DOI: 10.1016/j.biopha.2020.110603] [Reference Citation Analysis]
11 Moulignier A, Costagliola D. Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders. Curr Top Behav Neurosci 2021;50:367-99. [PMID: 31989463 DOI: 10.1007/7854_2019_123] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Suciu BD, Păunescu RL, Micluţia IV. Assessment of cognitive performances in major depressed patients: a 6-month follow-up study. Int J Psychiatry Clin Pract 2021;25:378-84. [PMID: 33118408 DOI: 10.1080/13651501.2020.1840595] [Reference Citation Analysis]
13 Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM. Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property. Front Pharmacol 2021;12:640241. [PMID: 33716753 DOI: 10.3389/fphar.2021.640241] [Reference Citation Analysis]
14 Balanzá-Martínez V, Shansis FM, Tatay-Manteiga A, López-García P. Diet and Neurocognition in Mood Disorders - An Overview of the Overlooked. Curr Pharm Des 2020;26:2353-62. [PMID: 32188376 DOI: 10.2174/1381612826666200318152530] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Chai Y, Cai Y, Fu Y, Wang Y, Zhang Y, Zhang X, Zhu L, Miao M, Yan T. Salidroside Ameliorates Depression by Suppressing NLRP3-Mediated Pyroptosis via P2X7/NF-κB/NLRP3 Signaling Pathway. Front Pharmacol 2022;13:812362. [DOI: 10.3389/fphar.2022.812362] [Reference Citation Analysis]
16 Szopa A, Socała K, Serefko A, Doboszewska U, Wróbel A, Poleszak E, Wlaź P. Purinergic transmission in depressive disorders. Pharmacol Ther 2021;224:107821. [PMID: 33607148 DOI: 10.1016/j.pharmthera.2021.107821] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]